Analysis of inhibitory mechanism and antithrombotic effects of a novel anti-platelet function molecule, semaphorin 3A
| Project/Area Number |
20591151
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Hematology
|
|---|
| Research Institution | Osaka University |
|---|
Principal Investigator |
KASHIWAGI Hirokazu Osaka University, 医学系研究科, 助教 (10432535)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
TOMIYAMA Yoshiaki 大阪大学, 医学部附属病院, 講師 (80252667)
|
|---|
| Project Period (FY) |
2008 – 2010
|
| Project Status |
Completed (Fiscal Year 2010)
|
| Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2010: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2009: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2008: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
|---|
| Keywords | 血小板 / セマフォリン / シグナル伝達 / 血栓 / 動脈硬化 |
|---|
| Research Abstract |
We analyzed the mechanism of inhibition of platelet function by semaphorin 3A. In addition to inhibition of actin polymerization via suppression of Rac-paxillin pathway, we found that semaphorin 3A inhibits downstream molecules of PI3 kinase, Rap1 and AKT. Interestingly, semaphorin 3A inhibited both thrombin-or convulxin-induced Rap1 and AKT activation, it inhibited mainly ADP-induced AKT phosphorylation. These results indicate that semaphorin 3A inhibits PI3 kinase pathway, and it may have direct inhibitory effects on ADP-induced AKT activation.
|
Report
(4 results)
Research Products
(122 results)
